In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.